BCRX icon

BioCryst Pharmaceuticals

123 hedge funds and large institutions have $938M invested in BioCryst Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 41 increasing their positions, 27 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
123
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$9.82M
Puts
$10.8M
Net Calls
Net Calls Change

Top Buyers

1 +$16.4M
2 +$11.3M
3 +$11.2M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$8.18M
5
PA
Perceptive Advisors
New York
+$7.02M

Top Sellers

1 -$64.5M
2 -$20.5M
3 -$18M
4
Millennium Management
Millennium Management
New York
-$7.68M
5
AQR Capital Management
AQR Capital Management
Connecticut
-$3.08M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$447K
77
$431K
78
$426K
79
$423K
80
$416K
81
$372K
82
$329K
83
$302K
84
$299K
85
$283K
86
$279K
87
$258K
88
$256K
89
$253K
90
$228K
91
$215K
92
$208K
93
$199K
94
$179K
95
$175K
96
$170K
97
$163K
98
$159K
99
$150K
100
$120K